Cancer Immunotherapy Researcher to Speak September 23


Cancer Immunotherapy Researcher
To Speak at West Virginia State University

     James W. Hodge, Ph.D. will speak at the College of Natural Science and Mathematics Convocation on Thursday, September 23 at 12:25 p.m. in the Hamblin Hall Auditorium The event, which is also part of the Faculty Lecture Series, is open to the public. Dr. Hodge is Director of the Recombinant Vaccine Group in the Laboratory of Tumor Immunology and Biology, National Cancer Institute.
     He is active in the area of tumor immunity, and has made significant contributions to the design and development of novel recombinant vaccines and vaccine strategies for cancer immunotherapy including a) recombinant vectors to deliver tumor antigens, b) the use of costimulation to enhance antitumor T-cell responses, c) the use whole tumor cell vaccines, and d) the use of diversified prime and boost strategies to enhance antitumor immunity. The concepts and therapeutics developed within the Recombinant Vaccine Group have been translated into more than 40 clinical trials.
     For additional information contact the WVSU College of Natural Science and Mathematics at 304.766.3142.

Scroll to Top